Will Intelligent Manufacture and Emerging Technologies...
From our September 1 issue: Chromatin...
The Role of Physical Barriers and...
Increasing Efficiency and Productivity in Bioanalysis
Biotechnology equipment spells big bucks for the industry’s top CEOs. [© ALYUSHIN - Fotolia.com]
Olivier A. Filliol, President and CEO
2011 Compensation: $5,379,639
2010 Compensation: $5,393,903
% Change: -0.3%
Marc N. Casper, President and CEO
2011 Compensation: $5,516,567
2010 Compensation: $2,761,689
% Change: 99.8%
Jay T. Flatley, President, CEO and Director
2011 Compensation: $9,944,147
2010 Compensation: $6,608,974
% Change: 50.5%
Edward J. Ludwig, Chairman and CEO
2011 Compensation: $10,091,273
2010 Compensation: $10,005,022
% Change: 0.9%
William P. Sullivan, President and CEO
2011 Compensation: $10,252,264
2010 Compensation: $10,442,447
% Change: -1.8%
Gregory T. Lucier, Chairman and CEO
2011 Compensation: $10,897,630
2010 Compensation: $11,498,009
% Change: -5.2%
Robert F. Friel, Chairman and CEO
2011 Compensation: $12,819,181
2010 Compensation: $7,948,297
% Change: 61.3%
Leave a comment by clicking the “Comments” icon. We want to hear your thoughts!
Do you think all new cancer drugs awaiting approval should undergo value-pricing?
Be sure to add firstname.lastname@example.org
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2015 Genetic Engineering & Biotechnology News All Rights Reserved